Targeting the ANG2/TIE2 Axis Inhibits Tumor Growth and Metastasis by Impairing Angiogenesis and Disabling Rebounds of Proangiogenic Myeloid Cells-Reference-Cited by-同舟云学术

Targeting the ANG2/TIE2 Axis Inhibits Tumor Growth and Metastasis by Impairing Angiogenesis and Disabling Rebounds of Proangiogenic Myeloid Cells

Published:2011-04 Issue:4 Volume:19 Page:512-526
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Mazzieri Roberta,Pucci Ferdinando,Moi Davide,Zonari Erika,Ranghetti Anna,Berti Alvise,Politi Letterio S.,Gentner Bernhard,Brown Jeffrey L.,Naldini Luigi,De Palma Michele

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference46 articles.

1. Regulated and multiple miRNA and siRNA delivery into primary cells by a lentiviral platform;Amendola;Mol. Ther.,2009

2. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche;Arai;Cell,2004

3. Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system;Augustin;Nat. Rev. Mol. Cell Biol.,2009

4. Modes of resistance to anti-angiogenic therapy;Bergers;Nat. Rev. Cancer,2008

5. A human monoclonal anti-ANG2 antibody leads to broad antitumor activity in combination with VEGF inhibitors and chemotherapy agents in preclinical models;Brown;Mol. Cancer Ther.,2010

Cited by 534 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. References;The Evolution of Immunotherapy Against Tumors;2025

2. Melatonin downregulates angiogenesis and lymphangiogenesis by regulating tumor-associated macrophages via NLRP3 inflammasomes in lung adenocarcinoma;Aging;2024-09-03

3. Macrophage polarization in the tumor microenvironment: Emerging roles and therapeutic potentials;Biomedicine & Pharmacotherapy;2024-08

4. The Tie-2 antagonist rebastinib reduces ovarian cancer growth in a syngeneic murine model;2024-07-25

5. An update to experimental and clinical aspects of tumor-associated macrophages in cancer development: hopes and pitfalls;Clinical and Experimental Medicine;2024-07-13